Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b10c5a760d03428721bb801301dd634c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
filingDate |
1993-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccca19f557e0e7e7205f331ad026b41c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_094f4ce1e4748bf06ef9b044fb9711e9 |
publicationDate |
1994-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0602686-A2 |
titleOfInvention |
Lectin concentrates of mistletoe extracts and corresponding standardized, stabilized mistletoe lectin preparations, process for their production as well as medicines containing them and their use |
abstract |
Mistletoe lectin concentrates with a high proportion of immunologically active galactoid-specific mistletoe lectins as well as corresponding stabilized and standardized immunologically active mistletoe lectin preparations are described, the production of the mistletoe lectin concentrates is described by means of a two-stage fractionation process, and also the production of the mistletoe lectin preparations containing mistletoe lectin fractions. These mistletoe lectin preparations have a defined high content of immunologically active galactoside-specific mistletoe lectins and a defined biological activity and accordingly allow an exatly adjustable dosage tailored to the respective treatment purpose. They are used advantageously to increase natural immune resistance in humans and mammals and / or for tumor therapy. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6379714-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7052702-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9711967-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0824355-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5780037-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3243523-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9813053-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9724136-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7208466-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8377654-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004058813-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2493915-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0824355-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19548367-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7452543-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115025207-A |
priorityDate |
1992-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |